Atlas Trials

Safety, Tolerability, PK and PD of Intravenous Ferric Carboxymaltose in Infants With Iron Deficiency Anemia

Clinical trial NCT04968379 · WITHDRAWN

Trial details

NCT number
NCT04968379
Sponsor
American Regent, Inc.
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Iron Deficiency, Anaemia
Start date
2022-07-21
Primary completion
2024-10-08
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.